Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethical issues in DNA testing.

S M Pulst1

  • 1Rose Moss Laboratory for Parkinson Disease and Neurodegenerative Disorders, Burns and Allen Research Institute, Division of Neurology, Cedars-Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Boulevard, Los Angeles, California 90048, USA.

Muscle & Nerve
|September 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

Cerebellum (London, England)·2013
Same author

In Vitro Cytotoxic Effects of Dibromodulcitol in 9L Rat Brain Tumor Cells.

Pharmaceutical research·2013
Same author

Sca13.

Cerebellum (London, England)·2008
Same author

An autosomal dominant ataxia maps to 19q13: Allelic heterogeneity of SCA13 or novel locus?

Neurology·2005
Same author

Screening for mutations in synaptotagmin XI in Parkinson's disease.

Journal of neural transmission. Supplementum·2004
Same author

Immunocytochemical characterization of torsin proteins in mouse brain.

Brain research·2001
Same journal

Cytokine Profiles in Myasthenia Gravis Subgroups and the Lack of Any Effect of Immunosuppression.

Muscle & nerve·2026
Same journal

Fatigue in Myasthenia Gravis: Recent Advances and Emerging Concepts.

Muscle & nerve·2026
Same journal

Presynaptic Congenital Myasthenic Syndromes.

Muscle & nerve·2026
Same journal

AGRN-, LRP4-, MUSK-Related CMS: Clinical, Neurophysiological, Morphological, Genetic and Pathological Mechanisms.

Muscle & nerve·2026
Same journal

The Differing Phenotypes of the Three Most Common Postsynaptic Congenital Myasthenic Syndromes Governed by Their Underlying Molecular Pathogenic Mechanisms.

Muscle & nerve·2026
Same journal

IgG Subclass (IgG1-4) and IgA Autoantibody Profiles Against Muscle-Specific Kinase in a Greek Cohort.

Muscle & nerve·2026
See all related articles

Molecular DNA testing for single gene disorders is highly accurate but lacks real-world outcomes data. Ethical considerations and educational needs for patients and providers require further investigation.

Area of Science:

  • Genetics and Molecular Biology
  • Medical Ethics
  • Neurology

Background:

  • Molecular genetic testing is the gold standard for diagnosing single gene disorders, exceeding traditional methods.
  • Despite technical reliability, outcomes data for DNA tests in non-academic settings are scarce.
  • Ethical discussions surrounding DNA testing are largely theoretical, with limited real-world case studies.

Purpose of the Study:

  • To evaluate the sensitivity, specificity, and clinical utility of molecular DNA tests outside academic centers.
  • To explore the ethical dilemmas and practical challenges associated with DNA testing in real-life scenarios.
  • To highlight the need for scientific investigation into the societal implications of genetic information.

Main Methods:

  • Review of existing literature on molecular test performance and outcomes.

Related Experiment Videos

  • Analysis of reported ethical challenges and their resolution in clinical practice.
  • Discussion of potential societal impacts based on current understanding.

    • Main Results:

    • Direct technical issues with DNA tests are infrequent.
    • Limited published research exists on the real-world sensitivity, specificity, and usage of these tests.
    • Ethical dilemmas are primarily discussed theoretically, with minimal documented case reports or follow-up.

    Conclusions:

    • There is a critical need for more outcomes research on molecular genetic testing in diverse clinical settings.
    • Societal and ethical implications, including data privacy and potential misuse of genetic information, require thorough investigation.
    • Enhanced education for patients, healthcare providers, and the public is essential to contextualize genetic information within broader health determinants.